Deutsche Bank Ag\ Veracyte, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Veracyte, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 57,069 shares of VCYT stock, worth $2.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,069

Previous 41,491 37.55%

Holding current value

$2.45 Million

Previous $899,000 116.02%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$21.0 - $35.25 $327,138 - $549,124	15,578 Added 37.55%	57,069 $1.94 Million
Q2 2024 Aug 14, 2024	SELL	$18.86 - $23.55 $83,851 - $104,703	-4,446 Reduced 9.68%	41,491 $899,000
Q1 2024 May 15, 2024	BUY	$21.0 - $29.1 $126,882 - $175,822	6,042 Added 15.14%	45,937 $1.02 Million
Q4 2023 Feb 14, 2024	SELL	$19.72 - $28.68 $15,006 - $21,825	-761 Reduced 1.87%	39,895 $1.1 Million
Q3 2023 Nov 09, 2023	BUY	$22.33 - $29.92 $95,505 - $127,967	4,277 Added 11.76%	40,656 $907,000
Q2 2023 Aug 14, 2023	SELL	$20.96 - $26.99 $1.16 Million - $1.5 Million	-55,407 Reduced 60.37%	36,379 $926,000
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $928,693 - $1.26 Million	45,126 Added 96.71%	91,786 $2.05 Million
Q4 2022 Feb 13, 2023	BUY	$15.31 - $29.94 $132,079 - $258,292	8,627 Added 22.68%	46,660 $1.11 Million
Q3 2022 Nov 14, 2022	SELL	$16.58 - $27.9 $85,221 - $143,406	-5,140 Reduced 11.91%	38,033 $632,000
Q2 2022 Aug 11, 2022	SELL	$15.45 - $29.52 $708,753 - $1.35 Million	-45,874 Reduced 51.52%	43,173 $860,000
Q1 2022 May 13, 2022	SELL	$21.94 - $42.51 $93,332 - $180,837	-4,254 Reduced 4.56%	89,047 $2.45 Million
Q4 2021 Feb 11, 2022	BUY	$36.09 - $53.79 $685 - $1,022	19 Added 0.02%	93,301 $3.84 Million
Q3 2021 Nov 04, 2021	BUY	$35.62 - $52.97 $16,670 - $24,789	468 Added 0.5%	93,282 $4.34 Million
Q2 2021 Aug 11, 2021	SELL	$32.94 - $56.62 $109,690 - $188,544	-3,330 Reduced 3.46%	92,814 $3.71 Million
Q1 2021 May 13, 2021	BUY	$44.47 - $81.38 $1.13 Million - $2.07 Million	25,473 Added 36.04%	96,144 $5.17 Million
Q4 2020 Feb 16, 2021	BUY	$32.49 - $61.88 $865,208 - $1.65 Million	26,630 Added 60.47%	70,671 $3.46 Million
Q3 2020 Nov 12, 2020	BUY	$26.73 - $35.67 $221,351 - $295,383	8,281 Added 23.16%	44,041 $1.43 Million
Q2 2020 Aug 13, 2020	SELL	$19.49 - $28.11 $175,078 - $252,512	-8,983 Reduced 20.08%	35,760 $927,000
Q1 2020 May 14, 2020	BUY	$16.13 - $30.17 $451 - $844	28 Added 0.06%	44,743 $1.09 Million
Q4 2019 Feb 14, 2020	SELL	$20.78 - $29.99 $3.32 Million - $4.8 Million	-159,902 Reduced 78.15%	44,715 $1.25 Million
Q3 2019 Nov 14, 2019	SELL	$23.87 - $30.93 $7.07 Million - $9.16 Million	-296,121 Reduced 59.14%	204,617 $4.91 Million
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $5.45 Million - $7.05 Million	246,820 Added 97.2%	500,738 $14.3 Million
Q1 2019 May 15, 2019	BUY	$12.0 - $25.76 $1.51 Million - $3.24 Million	125,849 Added 98.27%	253,918 $6.35 Million
Q4 2018 Feb 14, 2019	SELL	$9.15 - $14.85 $5.22 Million - $8.47 Million	-570,661 Reduced 81.67%	128,069 $1.61 Million
Q3 2018 Dec 21, 2021	BUY	$9.55 - $12.64 $3.85 Million - $5.09 Million	403,030 Added 136.3%	698,730 $6.67 Million
Q3 2018 Nov 14, 2018	BUY	$9.55 - $12.64 $2.16 Million - $2.86 Million	225,989 Added 324.18%	295,700 $2.82 Million
Q2 2018 Apr 21, 2020	BUY	$5.39 - $9.66 $66,199 - $118,644	12,282 Added 21.39%	69,711 $651,000
Q2 2018 Aug 14, 2018	BUY	$5.39 - $9.66 $82,343 - $147,575	15,277 Added 36.24%	57,429 $536,000
Q1 2018 Oct 18, 2019	BUY	$5.44 - $6.97 $91,043 - $116,649	16,736 Added 65.85%	42,152 $232,000
Q1 2018 May 15, 2018	SELL	$5.44 - $6.97 $490,584 - $628,561	-90,181 Reduced 78.01%	25,416 $140,000
Q4 2017 Feb 14, 2018	BUY	$6.05 - $9.37 $41,557 - $64,362	6,869 Added 6.32%	115,597 $753,000
Q3 2017 Nov 14, 2017	BUY	$7.81 - $8.77 $849,165 - $953,544	108,728	108,728 $952,000

Others Institutions Holding VCYT

# of Institutions

310

Shares Held

81.7M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.07B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account